帕西尼和皮埃里尼的异常性肌肤:对酸治疗的反应
Monica Ceballos-Pérez1, Ilse Marilu Gutierrez Villarreal1, Ivan E Cano Lizarraga1
1Department of Dermatology, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) Monterrey Regional Hospital, Monterrey, MEX.
Cureus
|February 14, 2025
概括
帕西尼和皮埃里尼肌 (APP) 是一种罕见的皮肤疾病. 一项长达19年的案例研究显示,对一种新的治疗方法 - - 菌酸 (MPA) 治疗产生了良好的反应.
科学领域:
- 皮肤病学 皮肤病学
- 罕见的皮肤疾病 罕见的皮肤疾病
背景情况:
- 帕西尼和皮埃里尼肌 (APP) 是一种罕见的疾病,其特征是皮肤缩.
- 它的病因仍然未知,呈现为非强化,压抑的斑块.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
135
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
135


